학술논문
Adjuvant low-dose interleukin-2 (IL-2) plus interferon-α (IFN-α) in operable renal cell carcinoma (RCC): A phase III, randomized, multicentre trial of the italian oncology group for clinical research (GOIRC)
Document Type
Article
Author
Source
In: Journal of Immunotherapy . (Journal of Immunotherapy, 10 December 2014, 37(9):440-447)
Subject
Language
English
ISSN
15374513
15249557
15249557